CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,586 | -37.0% | 17,646 | 0.0% | 0.00% | – |
| Q2 2023 | $64,408 | +7.3% | 17,646 | +41.9% | 0.00% | – |
| Q1 2022 | $60,000 | -57.7% | 12,437 | -1.1% | 0.00% | – |
| Q4 2021 | $142,000 | -23.7% | 12,581 | -1.4% | 0.00% | – |
| Q3 2021 | $186,000 | -70.1% | 12,763 | -71.0% | 0.00% | – |
| Q1 2020 | $623,000 | -33.5% | 43,944 | -25.5% | 0.00% | – |
| Q4 2019 | $937,000 | – | 58,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |